![Pharmaceuticals | Free Full-Text | Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies Pharmaceuticals | Free Full-Text | Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-01278/article_deploy/html/images/pharmaceuticals-15-01278-g002.png)
Pharmaceuticals | Free Full-Text | Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
![PDF) Faecal microbiota transplantation for recurrent C. difficile infections: challenges and improvement opportunities for clinical practice and healthcare systems PDF) Faecal microbiota transplantation for recurrent C. difficile infections: challenges and improvement opportunities for clinical practice and healthcare systems](https://i1.rgstatic.net/publication/366177360_Faecal_microbiota_transplantation_for_recurrent_C_difficile_infections_challenges_and_improvement_opportunities_for_clinical_practice_and_healthcare_systems/links/6394d7b7e42faa7e75b188da/largepreview.png)
PDF) Faecal microbiota transplantation for recurrent C. difficile infections: challenges and improvement opportunities for clinical practice and healthcare systems
![The German experience with asbestos-related diseases: a failure of compensation due to the manipulation of science | Published in The Journal of Scientific Practice and Integrity The German experience with asbestos-related diseases: a failure of compensation due to the manipulation of science | Published in The Journal of Scientific Practice and Integrity](https://www.jospi.org/article/89389-the-german-experience-with-asbestos-related-diseases-a-failure-of-compensation-due-to-the-manipulation-of-science/attachment/185780.png)
The German experience with asbestos-related diseases: a failure of compensation due to the manipulation of science | Published in The Journal of Scientific Practice and Integrity
![Roles of IL‐2 in bridging adaptive and innate immunity, and as a tool for cellular immunotherapy - Bendickova - 2020 - Journal of Leukocyte Biology - Wiley Online Library Roles of IL‐2 in bridging adaptive and innate immunity, and as a tool for cellular immunotherapy - Bendickova - 2020 - Journal of Leukocyte Biology - Wiley Online Library](https://jlb.onlinelibrary.wiley.com/cms/asset/2872150c-3976-4668-a2de-8ccdf3165a1c/jlb10682-fig-0001-m.jpg)
Roles of IL‐2 in bridging adaptive and innate immunity, and as a tool for cellular immunotherapy - Bendickova - 2020 - Journal of Leukocyte Biology - Wiley Online Library
![Plasma Exchange to Treat Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome after Anti-CD19 Chimeric Antigen Receptor-T Cell Infusion: A Case Report Plasma Exchange to Treat Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome after Anti-CD19 Chimeric Antigen Receptor-T Cell Infusion: A Case Report](http://dr.clintile.com/fileJBYYJ/journal/article/dr/2021/1/2021-01005-2.jpg)
Plasma Exchange to Treat Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome after Anti-CD19 Chimeric Antigen Receptor-T Cell Infusion: A Case Report
![PDF) Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma PDF) Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma](https://i1.rgstatic.net/publication/380032279_Targeting_NRAS_via_miR-1304-5p_or_farnesyltransferase_inhibition_confers_sensitivity_to_ALK_inhibitors_in_ALK-mutant_neuroblastoma/links/6628769543f8df018d2578b0/largepreview.png)
PDF) Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma
![Pharmaceuticals | Free Full-Text | Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies Pharmaceuticals | Free Full-Text | Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-15-01278/article_deploy/html/images/pharmaceuticals-15-01278-ag.png?1666341947)
Pharmaceuticals | Free Full-Text | Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
![Vaccines | Free Full-Text | Intranasal Liposomal Formulation of Spike Protein Adjuvanted with CpG Protects and Boosts Heterologous Immunity of hACE2 Transgenic Mice to SARS-CoV-2 Infection Vaccines | Free Full-Text | Intranasal Liposomal Formulation of Spike Protein Adjuvanted with CpG Protects and Boosts Heterologous Immunity of hACE2 Transgenic Mice to SARS-CoV-2 Infection](https://www.mdpi.com/vaccines/vaccines-11-01732/article_deploy/html/images/vaccines-11-01732-g001.png)